KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Current Taxes (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 14 years of Current Taxes data on record, last reported at $56.4 million in Q4 2025.

  • For Q4 2025, Current Taxes rose 200.62% year-over-year to $56.4 million; the TTM value through Dec 2025 reached $56.4 million, up 200.62%, while the annual FY2025 figure was $56.4 million, 200.62% up from the prior year.
  • Current Taxes reached $56.4 million in Q4 2025 per JAZZ's latest filing, down from $91.1 million in the prior quarter.
  • Across five years, Current Taxes topped out at $91.1 million in Q3 2025 and bottomed at $3.6 million in Q2 2021.
  • Average Current Taxes over 5 years is $40.6 million, with a median of $37.6 million recorded in 2023.
  • Peak YoY movement for Current Taxes: plummeted 93.49% in 2021, then soared 1065.1% in 2023.
  • A 5-year view of Current Taxes shows it stood at $9.6 million in 2021, then dropped by 19.68% to $7.7 million in 2022, then skyrocketed by 354.5% to $35.1 million in 2023, then tumbled by 46.52% to $18.8 million in 2024, then soared by 200.62% to $56.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $56.4 million in Q4 2025, $91.1 million in Q3 2025, and $78.6 million in Q2 2025.